Key result
Restoring balanced cytosolic calcium cycling holds therapeutic potential to reverse pathological myocardial remodeling in HF.
Why the study?
Calcium overload and dysregulated calcium handling drive HF progression, highlighting the need to characterize functional defects in calcium regulatory machinery and targeted therapeutics.
Restoration of balanced cytosolic calcium cycling holds therapeutic potential to reverse pathological myocardial remodeling in heart failure.
Answers are grounded in this paper and cite their sources.
Multi-target calcium modulation merits clinical evaluation in HF; extends mechanistic synthesis but leaves translation open pending trials.
Cardiovascular diseases rank as the global primary cause of mortality. Heart failure (HF) represents a progressive cardiac syndrome triggered by structural or functional myocardial damage that compromises ventricular systolic output. Intracellular calcium homeostasis underpins cardiomyocyte excitation-contraction coupling. Calcium overload and dysregulated calcium handling act as central pathogenic forces driving HF progression. Sympathetic β 1 -adrenergic receptor (β 1 -AR) and parasympathetic M 2 muscarinic acetylcholine receptor (M 2 -AChR) coordinate dual regulatory signaling to control cardiac calcium turnover, alongside key modulators including L-type calcium channel (LTCC), ryanodine receptor 2 (RyR2), SERCA2a, cardiac troponin C (cTnC), Na + /Ca 2+ exchanger 1 (NCX1) and mitochondrial permeability transition pore (MPTP). This review outlines physiological calcium cycling and systematically characterizes HF-related functional defects of calcium regulatory machinery from three layers: calcium release, sarcoplasmic reticulum calcium reuptake and auxiliary calcium mediators. We further discuss the underlying mechanisms of calcium-targeted pharmaceuticals and gene therapeutic approaches, while addressing translational bottlenecks limiting single-target interventions. Restoration of balanced cytosolic calcium cycling holds therapeutic potential to reverse pathological myocardial remodeling in HF.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) conducted a review in Heart failure. Restoration of balanced cytosolic calcium cycling holds therapeutic potential to reverse pathological myocardial remodeling in heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: